Evidence map›Paper›PMID 36733850›Full record

ArticleFrontiers in cellular and infection microbiology2022

Sana Jemel, Yannick Raveloarisaona, Anne-Laure Bidaud, Elie Djenontin, Aicha Kallel, Jacques Guillot, Kalthoum Kallel, Françoise Botterel, Eric Dannaoui

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Oxidoreductase geneMicrobiology spectrum · 2026
    Article
  3. Review
  4. Review
  5. Characterization ofJournal of medical microbiology · 2024
    Article
  6. Pathogens (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Sana JemelUniversité Paris Est Créteil, Dynamyc, Créteil, France.
Yannick RaveloarisaonaUnité de Parasitologie-Mycologie, Service de Microbiologie, Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Européen Georges Pompidou, Paris, France.
Anne-Laure BidaudUnité de Parasitologie-Mycologie, Service de Microbiologie, Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Européen Georges Pompidou, Paris, France.
Elie DjenontinUniversité Paris Est Créteil, Dynamyc, Créteil, France.
Aicha KallelUniversité Tunis EL Manar, Faculté de médecine de Tunis, Tunis, Tunisie.
Jacques GuillotDermatology-Parasitology-Mycology, Oniris, Nantes, France.
Kalthoum KallelUniversité Tunis EL Manar, Faculté de médecine de Tunis, Tunis, Tunisie.
Françoise BotterelUniversité Paris Est Créteil, Dynamyc, Créteil, France.
Eric DannaouiUniversité Paris Est Créteil, Dynamyc, Créteil, France.
Hôpital Européen · FRTunis University · TNAssistance Publique – Hôpitaux de Paris · FRFaculté de médecine de TunisUniversité de Bretagne Occidentale · FRUniversité Paris Cité · FRUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azole resistance in

Indexed as

Antifungal AgentsAspergillosisAnimalsAspergillus fumigatusAzolesCaspofunginDrug Resistance, FungalLarvaMicrobial Sensitivity TestsVoriconazoleAntifungal AgentsAzolesCaspofunginVoriconazoleantifungal combinationAspergillus fumigatus (A. fumigatus)azole-resistancecaspofunginGalleria mellonellaposaconazolevoriconazole

Identifiers

PMID36733850
PMCPMC9887171
OpenAlexW4316672177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.